Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

Hepatocellular carcinoma (HCC), the third major cause of cancer mortality, can result from non-alcoholic steatohepatitis (NASH). Due to limited efficacy of drugs approved for HCC and no drug available yet for NASH, identification of new effective treatments is crucial. Here, we investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Joseph, Serrano, Sonia Simón, Grönberg, Alvar, Massoumi, Ramin, Hansson, Magnus Joakim, Gallay, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775500/
https://www.ncbi.nlm.nih.gov/pubmed/31611801
http://dx.doi.org/10.3389/fphar.2019.01129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775500/
https://www.ncbi.nlm.nih.gov/pubmed/31611801
http://dx.doi.org/10.3389/fphar.2019.01129

Ejemplares similares